Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3055 | 2077 | 36.2 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
3055 | 1 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE | 2077 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LAMOTRIGINE | authKW | 2328720 | 22% | 34% | 462 |
2 | FELBAMATE | authKW | 1330549 | 6% | 71% | 128 |
3 | OXCARBAZEPINE | authKW | 1145643 | 9% | 41% | 191 |
4 | ANTIEPILEPTIC DRUGS | authKW | 504767 | 17% | 10% | 345 |
5 | ANTICONVULSANTS | authKW | 142756 | 8% | 6% | 163 |
6 | EPILEPSY | authKW | 136316 | 22% | 2% | 461 |
7 | 10 HYDROXYCARBAZEPINE | authKW | 133634 | 0% | 91% | 10 |
8 | MONOTHERAPY | authKW | 124339 | 4% | 10% | 82 |
9 | TRILEPTAL | authKW | 117599 | 0% | 100% | 8 |
10 | GABAPENTIN | authKW | 103481 | 5% | 7% | 100 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 30544 | 52% | 0% | 1090 |
2 | Pharmacology & Pharmacy | 4261 | 28% | 0% | 578 |
3 | Psychiatry | 1615 | 11% | 0% | 228 |
4 | Medical Laboratory Technology | 1152 | 4% | 0% | 86 |
5 | Neurosciences | 775 | 14% | 0% | 281 |
6 | Toxicology | 673 | 6% | 0% | 127 |
7 | Chemistry, Analytical | 387 | 7% | 0% | 152 |
8 | Behavioral Sciences | 292 | 3% | 0% | 65 |
9 | Education, Special | 272 | 1% | 0% | 26 |
10 | Biochemical Research Methods | 201 | 4% | 0% | 88 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NIJMEGEN EPILEPSY GRP | 44100 | 0% | 100% | 3 |
2 | EPILEPSY UNIT | 41246 | 2% | 7% | 41 |
3 | PHARMACOL THER EUT UNIT | 34122 | 1% | 19% | 12 |
4 | UDI IPG UNIT INLAND DEV | 33073 | 0% | 75% | 3 |
5 | CLIN PHARMACOL SERV PHYSIOL PHARMACOL | 29400 | 0% | 100% | 2 |
6 | DIE WEISSENAU | 29400 | 0% | 100% | 2 |
7 | NEW JERSEY COMPREHENS EPILEPSY | 29400 | 0% | 100% | 2 |
8 | PEDIAT EPILEPSY PEDIAT | 29400 | 0% | 100% | 2 |
9 | SECT EPILEPSY CLIN NEUROPHYSIOL | 29400 | 0% | 100% | 2 |
10 | CHILDRENS COMPREHENS EPILEPSY PROGRAM | 28263 | 0% | 38% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 101562 | 12% | 3% | 248 |
2 | EPILEPSY RESEARCH | 63124 | 6% | 3% | 129 |
3 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 47884 | 4% | 4% | 89 |
4 | THERAPEUTIC DRUG MONITORING | 18653 | 3% | 2% | 69 |
5 | EPILEPSY & BEHAVIOR | 11230 | 3% | 1% | 56 |
6 | JOURNAL OF EPILEPSY | 8302 | 1% | 4% | 15 |
7 | CNS DRUGS | 7036 | 1% | 2% | 29 |
8 | SEIZURE | 6015 | 0% | 8% | 5 |
9 | REVISTA DE NEUROLOGIA | 5862 | 2% | 1% | 47 |
10 | NERVENHEILKUNDE | 4999 | 1% | 1% | 27 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LAMOTRIGINE | 2328720 | 22% | 34% | 462 | Search LAMOTRIGINE | Search LAMOTRIGINE |
2 | FELBAMATE | 1330549 | 6% | 71% | 128 | Search FELBAMATE | Search FELBAMATE |
3 | OXCARBAZEPINE | 1145643 | 9% | 41% | 191 | Search OXCARBAZEPINE | Search OXCARBAZEPINE |
4 | ANTIEPILEPTIC DRUGS | 504767 | 17% | 10% | 345 | Search ANTIEPILEPTIC+DRUGS | Search ANTIEPILEPTIC+DRUGS |
5 | ANTICONVULSANTS | 142756 | 8% | 6% | 163 | Search ANTICONVULSANTS | Search ANTICONVULSANTS |
6 | EPILEPSY | 136316 | 22% | 2% | 461 | Search EPILEPSY | Search EPILEPSY |
7 | 10 HYDROXYCARBAZEPINE | 133634 | 0% | 91% | 10 | Search 10+HYDROXYCARBAZEPINE | Search 10+HYDROXYCARBAZEPINE |
8 | MONOTHERAPY | 124339 | 4% | 10% | 82 | Search MONOTHERAPY | Search MONOTHERAPY |
9 | TRILEPTAL | 117599 | 0% | 100% | 8 | Search TRILEPTAL | Search TRILEPTAL |
10 | GABAPENTIN | 103481 | 5% | 7% | 100 | Search GABAPENTIN | Search GABAPENTIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ARMIJO, JA , HERRANZ, JL , (2007) RATIONAL COMBINATION THERAPY IN EPILEPSY. I. CONCEPTS AND FOUNDATIONS.REVISTA DE NEUROLOGIA. VOL. 45. ISSUE 2. P. 95-109 | 65 | 84% | 1 |
2 | DE LA PARTE, JFH , HORGA, A , (2006) OXCARBAZEPINE IN THE TREATMENT OF EPILEPSY A REVIEW AND UPDATE.REVISTA DE NEUROLOGIA. VOL. 42. ISSUE 2. P. 95-113 | 61 | 81% | 10 |
3 | MOHANRAJ, R , BRODIE, MJ , (2003) MEASURING THE EFFICACY OF ANTIEPILEPTIC DRUGS.SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. VOL. 12. ISSUE 7. P. 413-443 | 103 | 51% | 25 |
4 | BROWN, WM , AIKEN, SP , (1998) FELBAMATE: CLINICAL AND MOLECULAR ASPECTS OF A UNIQUE ANTIEPILEPTIC DRUG.CRITICAL REVIEWS IN NEUROBIOLOGY. VOL. 12. ISSUE 3. P. 205 -222 | 96 | 62% | 11 |
5 | MAY, TW , KORN-MERKER, E , RAMBECK, B , (2003) CLINICAL PHARMACOKINETICS OF OXCARBAZEPINE.CLINICAL PHARMACOKINETICS. VOL. 42. ISSUE 12. P. 1023-1042 | 55 | 82% | 93 |
6 | JOHANNESSEN, SI , BATTINO, D , BERRY, DJ , BIALER, M , KRAMER, G , TOMSON, T , PATSALOS, PN , (2003) THERAPEUTIC DRUG MONITORING OF THE NEWER ANTIEPILEPTIC DRUGS.THERAPEUTIC DRUG MONITORING. VOL. 25. ISSUE 3. P. 347 -363 | 77 | 51% | 173 |
7 | PATSALOS, PN , (2013) DRUG INTERACTIONS WITH THE NEWER ANTIEPILEPTIC DRUGS (AEDS)-PART 1: PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN AEDS.CLINICAL PHARMACOKINETICS. VOL. 52. ISSUE 11. P. 927-966 | 71 | 44% | 31 |
8 | VENTURA, S , RODRIGUES, M , POUSINH, S , FALCAO, A , ALVES, G , (2017) DETERMINATION OF LAMOTRIGINE IN HUMAN PLASMA AND SALIVA USING MICROEXTRACTION BY PACKED SORBENT AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-DIODE ARRAY DETECTION: AN INNOVATIVE BIOANALYTICAL TOOL FOR THERAPEUTIC DRUG MONITORING.MICROCHEMICAL JOURNAL. VOL. 130. ISSUE . P. 221 -228 | 45 | 70% | 0 |
9 | RABASSEDA, X , (2001) OXCARBAZEPINE: ANTICONVULSANT PROFILE AND SAFETY.DRUGS OF TODAY. VOL. 37. ISSUE 5. P. 333 -355 | 69 | 68% | 4 |
10 | GLAUSER, TA , (2001) OXCARBAZEPINE IN THE TREATMENT OF EPILEPSY.PHARMACOTHERAPY. VOL. 21. ISSUE 8. P. 904 -919 | 56 | 78% | 54 |
Classes with closest relation at Level 1 |